CXSL1400077 | 注射用重组抗人表皮生长因子受体2(HER2)单抗(曲妥珠单抗) | trastuzumab | Lyophilized | Biological Products(2) | New Drug Application | 2014-09-12 | 华兰基因工程有限公司 | Hualan Genetic Engineering Co Ltd | Certificate Issued | 2016-07-21 | view |
JYSB1200278 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2012-12-07 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Certificate Issued | 2013-07-18 | view |
JYSB0500021 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2005-05-12 | | | Certificate Issued | 2005-09-23 | view |
CYSB2400292 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | Supplementary Application | 2024-11-09 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
CYSB2000306 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2020-11-25 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | In Review | 2022-01-27 | view |
JYSF1800009 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2018-06-21 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Certificate Issued | 2018-07-13 | view |
JYSB1400069 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2014-06-10 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Certificate Issued | 2014-11-06 | view |
JYSB0900088 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2009-06-02 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Certificate Issued | 2009-11-16 | view |
CYSB2101216 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2021-10-09 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
JXSL1900066 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Import Drug Application | 2019-08-01 | 美信美达医药信息咨询(北京)有限责任公司 | Meixin Meida Medical Information Consulting (Beijing) Co Ltd | In Review | 2019-07-31 | view |
JYSB1500163 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2015-06-05 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Certificate Issued | 2015-09-08 | view |
JXSL1000028 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Import Drug Application | 2010-07-15 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Certificate Issued | 2012-08-14 | view |
JYSB2300117 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2023-07-12 | | | | | view |
BS20020011 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Import Drug Application | 2002-09-25 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Approval Completed-Pending Certificated | 2003-05-08 | view |
CYSB2400136 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | Supplementary Application | 2024-05-25 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
JYSB2000360 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.1) | Supplementary Application | 2020-08-04 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Filed | 2020-08-17 | view |
JYSB1700172 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2017-09-27 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Certificate Issued | 2018-05-30 | view |
JYSB1300191 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2013-08-09 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Certificate Issued | 2014-11-25 | view |
JXSL0700010 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(7) | Import Drug Application | 2007-04-20 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Certificate Issued | 2009-01-08 | view |
CXSS2101019 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | New Drug Application | 2021-08-05 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |